Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2026 12:40 ET | Source: Ocubio

Ocubio Announces Appointment of Jim Mazzo and Dr. Eric Donnenfeld as Strategic Advisors

James Mazzo and Dr. Eric Donnenfeld are joining Ocubio as Strategic Advisors.
April 29, 2026 13:00 ET | Source: Centurion Service Group: A TRIMEDX Company

Centurion Service Group and Auction Advisors announce major auction of assets from Fromer Eye Centers

Franklin Park, Illinois, April 29, 2026 (GLOBE NEWSWIRE) -- Centurion Service Group, an industry-leading medical equipment lifecycle organization, in partnership with Auction Advisors, LLC, a...
April 07, 2026 09:11 ET | Source: Cellution Biologics

Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™

Cellution Biologics launches OptiCover™, a shelf-stable amniotic graft with HC-HA/PTX3, at ASCRS to address dry eye and ocular surface repair.
March 12, 2026 06:15 ET | Source: DigitalOptometrics

DigitalOptometrics® Announces Next Evolution in Tele-Ophthalmic Care at Vision Expo East

DigitalOptometrics® Announces Next Evolution in Tele-Ophthalmic Care at Vision Expo East
March 03, 2026 07:02 ET | Source: EyeMD EMR Healthcare Systems, LLC

Optivate Is Here: A New Name, a Bolder Vision, and Continued Commitment to Elevating Ophthalmology

Optivate Is Here: A New Name, a Bolder Vision, and Continued Commitment to Elevating Ophthalmology
January 30, 2026 11:30 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting

LONDON and NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 28, 2026 07:40 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Successful Type C Meeting with the FDA

LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 27, 2026 09:00 ET | Source: Nextech Systems, Inc.

Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe

Tampa, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Specialty-specific clinical documentation requires more than a generic, automated note taker to truly improve the charting process. Today, Nextech – an...
January 05, 2026 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer

Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on...
December 15, 2025 04:19 ET | Source: Research and Markets

Emerging Trends and Strategic Recommendations for Ophthalmology Industry Leaders Capitalizing on Technological Advancements

Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology & Optometry Equipment Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The evolution of...